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Abstract—Day-by-day blood pressure and heart rate variability defined as within-subject SDs of home measurements can
be calculated from long-term self-measurement. We investigated the prognostic value of day-by-day variability in 2455
Ohasama, Japan, residents (baseline age: 35 to 96 years; 60.4% women). Home blood pressure and heart rate were
measured once every morning for 26 days (median). A total of 462 deaths occurred over a median of 11.9 years,
composing 168 cardiovascular deaths (stroke: n83; cardiac: n85) and 294 noncardiovascular deaths. Using Cox
regression, we computed hazard ratios while adjusting for baseline characteristics, including blood pressure and heart
rate level, sex, age, obesity, current smoking and drinking habits, history of cardiovascular disease, diabetes mellitus,
hyperlipidemia, and treatment with antihypertensive drugs. An increase in systolic blood pressure variability of 1
between-subject SD was associated with increased hazard ratios for cardiovascular (1.27; P0.002) and stroke mortality
(1.41; P0.0009) but not for cardiac mortality (1.13; P0.26). Conversely, heart rate variability was associated with
cardiovascular (1.24; P0.002) and cardiac mortality (1.30; P0.003) but not stroke mortality (1.17; P0.12). Similar
findings were observed for diastolic blood pressure variability. Additional adjustment of heart rate variability for systolic
blood pressure variability and vice versa produced confirmatory results. Coefficient of variation, defined as
within-subject SD divided by level of blood pressure or heart rate, displayed similar prognostic value. In conclusion,
day-by-day blood pressure variability and heart rate variability by self-measurement at home make up a simple method
of providing useful clinical information for assessing cardiovascular risk. (Hypertension. 2008;52:1045-1050.)
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Home blood pressure measurement is reportedly morereliable than conventional blood pressure measurement,
because this approach avoids both observer and regression
dilution biases and eliminates the white coat effect.1 Home
blood pressure measurement offers more prognostic signifi-
cance than office blood pressure2 and is more indicative of
target organ damage.3 The clinical significance of home
blood pressure measurement is primarily produced by multi-
ple measurements of blood pressure.2 These multiple mea-
surements also provide information on day-by-day blood
pressure variability under relatively controlled conditions.4
Previous studies of ambulatory blood pressure monitoring
have highlighted that circadian variation5 and short-term
blood pressure variability6 can predict cardiovascular events
above and beyond traditional risk factors. However, no
studies have investigated associations between home blood
pressure variability and cardiovascular events. We hypothe-
sized that day-by-day blood pressure variability derived from
self-measurement at home would provide further insights into
prognosis. The objective of the present study was to clarify
whether day-by-day variability in home blood pressure could
have prognostic significance in the general population. We
also tested the prognostic significance of variability in home
heart rate, because we had observed previously an association
between high home heart rate and increased risk of cardio-
vascular mortality.7
Methods
Design
This report was based on longitudinal observations of subjects who
have been participating in a blood pressure measurement project in
Ohasama, Iwate Prefecture, Japan, since 1987. Socioeconomic and
demographic characteristics of this region and details of the study
project have been described previously.2,6 The institutional review
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boards of Tohoku University School of Medicine and the Ohasama
Municipal Government Department of Health approved the study.
All of the participants provided written informed consent.
Study Population
From 1988 until 1995, we contacted all 4969 of the subjects 35
years old and living in 4 districts of Ohasama town. Subjects who
were not at home during the normal working hours of the study
nurses (n1057) and those hospitalized (n166) or incapacitated
(n94) were ineligible. Of the remaining 3652 residents, 2933
(80%) participated in baseline examinations and underwent follow-
up. We excluded 478 subjects because home heart rate had not been
measured (n53) or because home blood pressure (n415) or home
heart rate (n10) was based on averages of 10 readings (10 days).
We consider that 10 home blood pressure measurements are
necessary to provide a reliable SD of blood pressure. This criterion
was based on an observation in 153 inhabitants of Ohasama (mean
age: 63.510.1 years; 65.4% women) who measured home blood
pressure over 30 days that within-subject SD of home measurements
for the first 10 days (systolic: 9.03.7 mm Hg; diastolic:
6.32.7 mm Hg) did not differ significantly from that obtained over
30 days (systolic: 9.23.0 mm Hg; diastolic: 6.52.4 mm Hg;
P0.10). Given that home blood pressure measurement is easily
accepted by subjects and has a relatively low cost, using more
readings than the statistically reliable minimum number (10 read-
ings) thus appears reasonable to calculate the SD of blood pressure.
We, therefore, adopted a varying number of measurements. Finally,
the total number of subjects included in the present analyses was
2455.
Data Collection
At public health centers, trained nurses of Ohasama town measured
anthropometric characteristics. Physicians and/or public health
nurses instructed participants on how to perform home blood
pressure measurements. Participants were asked to measure blood
pressure and heart rate once every morning over a period of 4 weeks
using an oscillometric device (HEM 401C, Omron Healthcare)
within 1 hour of waking, with measurements performed in a sitting
position after 2 minutes of rest.4,8 Home hypertension was defined
as a morning blood pressure of 135 mm Hg systolic or 85 mm Hg
diastolic or as the use of antihypertensive drugs. We computed the
level and variability of home blood pressure as average and within-
subject SD of measurements, respectively.6 We also considered
coefficient of variation (CV), defined as the within-subject SD
divided by blood pressure level. Using the same procedure, we
defined the level and variability of home heart rate. In sensitivity
analyses, we tested the prognostic significance of the variability of
blood pressure and heart rate using only the first 10 days of data in
all 2455 of the subjects.
Study nurses administered a standardized questionnaire, inquiring
into medical history, intake of medications, and smoking and
drinking habits of each patient. Previous cardiovascular disease
included stroke, transient ischemic attack, coronary heart disease,
and atrial fibrillation. Venous blood samples were analyzed using
standard automated enzymatic methods for total cholesterol and
blood glucose. According to published criteria,9 diabetes mellitus
was defined as a fasting or random blood glucose level of 7.0 or
11.1 mmol/L, respectively, or as the use of antidiabetic drugs.
Hypercholesterolemia was a serum level of total cholesterol of
5.68 mmol/L (220 mg/dL) or use of lipid-lowering drugs. Obesity
was defined as a body mass index of 25 kg/m2.
Ascertainment of Events
We ascertained vital status until December 31, 2004, via resident
registration cards, which are the basis for pension and social security
benefits in Japan. Causes of death were obtained from the National
Japanese Mortality Registry. Diagnoses on death certificates were
verified against the medical charts of Ohasama hospital, where
90% of Ohasama residents undergo regular health checkups. End
points considered in the present analysis were death from all causes,
cardiovascular (International Classification of Diseases, 10th Revi-
sion [ICD-10] codes “I”) and noncardiovascular mortality, mortality
from stroke (ICD-10 code I6), intracerebral hemorrhage (ICD-10
code I61), cardiac disorders (ICD-10 codes I05, I11, I20–I25, I34,
I35, I38, I46–I50, I71, I74, I77, and I99), cerebral infarction (ICD-10
code I63), myocardial infarction (ICD-10 codes I21 and I22),
neoplasms (ICD-10 codes C00-D48), diseases of the respiratory
system (ICD-10 codes “J”), and senility (ICD-10 code R54). Thus,
cardiovascular mortality includes mortality from all stroke and
cardiac events. We only classified cause of death as senility when all
other diseases were excluded. Participants who died from other
causes or who were lost to follow-up were treated as censored.
Statistical Analysis
SAS 9.1 software (SAS Institute, Inc) was used for statistical
analysis. We compared means and proportions using the standard
normal z test for large samples or ANOVA and the 2 statistic,
respectively, and survival curves by Kaplan-Meier survival function
estimates for cardiovascular mortality across quartiles of blood
pressure and heart rate variability. Pearson’s correlation coefficients
were computed for blood pressure and heart rate parameters. In Cox
regression, the proportional hazards assumption was checked using
the Kolmogorov-type supremum test. We calculated hazard ratios of
variability (SD or CV of measurements) using multiple Cox regres-
sion while adjusting for baseline characteristics, including sex, age,
obesity, current smoking and drinking habits, history of cardiovas-
cular disease, diabetes mellitus, hyperlipidemia, and treatment with
antihypertensive drugs. In Cox models for SD of parameters (blood
pressure and heart rate), we also accounted for levels of the
parameters. In a fully adjusted model, we further accounted for heart
rate variability when analyzing blood pressure variability and vice
versa.
Results
Baseline Characteristics of Participants
The 2455 participants included 1483 women (60.4%) and
1021 patients with home hypertension (41.6%), of whom 741
(72.6%) were taking antihypertensive drugs. Mean values
were 59.412.3 years for age, 23.53.1 for body mass
index, and 5.00.9 mmol/L for total cholesterol. At enroll-
ment, 474 participants (19.3%) were current smokers and 472
(25.8%) reported intake of alcohol, 653 (26.6%) had hyper-
cholesterolemia, 232 (9.5%) had diabetes mellitus, and 131
(5.3%) had a history of cardiovascular disease. Mean number
of blood pressure readings per participant was 24.55.3. The
95th, 75th, 50th (median), 25th, and 5th percentile cutoff
values for the number of home readings were 30, 28, 26, 22,
and 13, respectively. Systolic/diastolic blood pressure levels
were 124.615.2/74.79.9 mm Hg, respectively. The SDs
and CVs of systolic/diastolic blood pressure were 8.63.2/
6.42.3 mm Hg and 6.92.3/5.21.9%, respectively. The
level, SD, and CV of heart rate were 67.47.8 bpm, 5.72.3
bpm, and 8.43.2%, respectively. Systolic blood pressure
correlated positively with the SD of systolic blood pressure
(r0.40). Heart rate also correlated positively with the SD
of heart rate (r0.32). Diastolic blood pressure, on the
other hand, did not correlate with SD of diastolic blood
pressure (r0.07). Blood pressure was not correlated with
heart rate (r0.06 for systolic; r0.03 for diastolic). In
contrast, SD of blood pressure correlated positively with SD
of heart rate (r0.28 for systolic; r0.39 for diastolic).
Age did not correlate with day-by-day variability of heart rate
(r0.027).
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Among 2455 study subjects, 1194 subjects (64.1% women;
mean age: 57.810.7 years) were re-examined with long-
term measurement (24.24.4 days) of home blood pressure
in the morning after 7.51.5 years (second examination).
Differences between baseline and second examination were
2 mm Hg for level, 1 mm Hg for SD, and 1% for the
CV of home blood pressure. In relation to home heart rate,
differences were also small (1 bpm and1%). Variabilities
(SD and CV) of both blood pressure and heart rate correlated
moderately with first and second examinations (0.30).
Analysis of Mortality
During follow-up (mean: 11.93.9 years; median: 11.9
years; 5th to 95th percentile interval: 3.8 to 16.9 years),
29 224 person-years were accrued. A total of 81 participants
(3.3%) were lost to follow-up. The total of 462 deaths
included 168 cardiovascular deaths (36.4%), with 83 strokes
(18.0%) and 85 cardiac deaths (18.4%). These results were
similar to mortality throughout Japan according to the Na-
tional Vital Statistics; total number of deaths in Japan in 2000
was 961 653, including 285 333 cardiovascular deaths
(29.7%), with 132 529 strokes (13.8%) and 152 804 cardiac
deaths (15.9%).10 Stroke deaths were because of cerebral
infarction in 51 subjects, intracerebral hemorrhage in 21
subjects, subarachnoid hemorrhage in 8 subjects, or other
cerebrovascular or ill-defined causes in 3 subjects. Cardiac
mortality included myocardial infarction (n33), heart fail-
ure (n18), sudden death (n7), chronic coronary heart
disease (n6), arrhythmia (n5), and various other cardiac
disorders (n16). Noncardiovascular deaths (n294) re-
sulted from neoplasms (n112), diseases of the respiratory
system (n69), senility (n21), suicide (n19), diseases of
the genitourinary system (n15), injuries (n14), diseases of
the digestive system (n13), and various other diseases (n31).
Cumulative incidence for cardiovascular mortality differed
across quartiles of the distributions of SDs for blood pressure
and heart rate (Figure 1; log-rank test; all P0.0001). In Cox
regression, the Kolmogorov-type supremum test showed that,
for all of the outcomes in relation to variability and level of
blood pressure and heart rate, the proportional hazards as-
sumption was satisfied (P0.11). With multiple adjustments
applied, both levels and variabilities of systolic blood pres-
sure and heart rate were independent and consistent predic-
tors of total and cardiovascular mortality (Table 1), with the
exception of SD of heart rate as a predictor of total mortality
(P0.31; fully adjusted model). In stepwise regression anal-
ysis for cardiovascular mortality in the fully adjusted model
with P values to enter and stay in the model at 0.10, we
identified sex (P0.0001), age (P0.0001), history of car-
diovascular disease (P0.0001), SD of systolic blood pres-
sure (P0.027), systolic blood pressure (P0.009), SD of
heart rate (P0.036), and heart rate (P0.029). When office
blood pressure level was included in the model instead of
home blood pressure level (n2243), both office blood
pressure (P0.004) and SD of home blood pressure
(P0.006) remained as significant predictors for cardiovas-
cular mortality. The predictive capacity for noncardiovascular
mortality was no longer significant when deaths within 2
years of enrollment were censored (P0.06).
Table 2 shows hazard ratios for cause-specific mortality in
cardiovascular death. The SD of systolic blood pressure was
predictive of stroke and cerebral infarction but not cardiac
disease. Conversely, SD of heart rate was predictive of
cardiac mortality and death from myocardial infarction but
not from stroke. The SD of heart rate was also significantly
associated with risk of neoplasms (hazard ratio: 1.24; 95%
CI: 1.04 to 1.49; P0.02), whereas this association was
weakened to a nonsignificant level when we censored deaths
within 2 years of enrollment (hazard ratio: 1.20; 95% CI: 0.99
to 1.46; P0.06). We did not find any association of
intracerebral hemorrhage (P0.74), neoplasms (P0.25),
diseases of the respiratory system (P0.10), or senility
(P0.16), with SD of either systolic blood pressure or heart
rate. We repeated all of the analyses using SD of diastolic
blood pressure instead of the SD of systolic blood pressure,
yielding results that were largely consistent. As sensitivity
analyses, we investigated the hazard ratio for SDs of blood
pressure and heart rate using only the first 10 days of data,
variabilities defined by CV, variabilities of evening mea-
surement, and variabilities of average of morning and
evening readings (the average of 2 measurement per day).
The results were largely confirmatory (for further clarifi-
cation, please see the online supplemental data, available
at http://hyper.ahajournals.org).
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Figure 1. Kaplan-Meier survival estimates for cardiovascular mortality across quartiles of day-by-day variability, ie, SD of systolic blood
pressure (left), diastolic blood pressure (middle), and heart rate (right). Q1 to Q4 indicate ascending quartiles; cutoff points were 6.5,
8.2, and 10.3 mm Hg for systolic; 4.9, 6.1, and 7.6 mm Hg for diastolic; and 4.2, 5.4, and 6.9 bpm for heart rate.
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The 10-year absolute risk was steeper with stroke mortality
than with cardiac mortality (Figure 2, left). In contrast, in
relation to SD of heart rate, the risk was steeper with cardiac
mortality than with stroke mortality (Figure 2, right). SDs of
systolic blood pressure and heart rate were significantly and
independently correlated with cardiovascular mortality (Figure 3).
Discussion
The key finding of the present study was that, in middle-aged
and older subjects recruited from a Japanese population,
day-by-day blood pressure and heart rate variability, defined
as within-subject SDs of home measurements, were predic-
tive of cardiovascular mortality, while adjusting for blood
pressure, heart rate, and other risk factors, including sex, age,
obesity, current smoking and drinking habits, history of
cardiovascular disease, diabetes mellitus, hyperlipidemia, and
treatment with antihypertensive drugs. CV of measurements
offered similar prognostic value. This study addressed for the
first time the prognostic implications of day-by-day blood
pressure and heart rate variability based on self-measurement
at home in a general population.
The link between variability and outcome may not neces-
sarily imply a cause-effect relationship. Errors in self-
measurements could have been responsible for failure to
constantly identify a hypertensive condition at the time of
different home measurement sessions. Underlying irregular-
Table 1. Hazard Ratios for Mortality According to Blood Pressure and Heart Rate Parameters
at Entry
Mortality Total* Cardiovascular* Noncardiovascular*
Deaths, n 462 168 294
Base model
Systolic BP, mm Hg 1.18 (1.07 to 1.31) 1.33 (1.13 to 1.57) 1.11 (0.98 to 1.26)
Heart rate, bpm 1.21 (1.11 to 1.31) 1.24 (1.08 to 1.42)§ 1.19 (1.07 to 1.32)
Adjusted
SD of systolic BP, mm Hg 1.21 (1.10 to 1.32) 1.27 (1.09 to 1.47)§ 1.17 (1.04 to 1.32)§
SD of heart rate, bpm 1.11 (1.02 to 1.21)‡ 1.24 (1.09 to 1.41)§ 1.03 (0.92 to 1.16)
Fully adjusted
Systolic BP, mm Hg 1.13 (1.01 to 1.25)‡ 1.26 (1.06 to 1.49)§ 1.06 (0.93 to 1.21)
Heart rate, bpm 1.19 (1.09 to 1.30) 1.16 (1.01 to 1.34)‡ 1.21 (1.07 to 1.35)
SD of systolic BP, mm Hg 1.18 (1.07 to 1.31) 1.20 (1.02 to 1.40)‡ 1.18 (1.04 to 1.34)§
SD of heart rate, bpm 1.05 (0.96 to 1.16) 1.18 (1.02 to 1.36)‡ 0.97 (0.86 to 1.10)
*Hazard ratios (95% CIs) reflect risk associated with an increase in parameters of 1 between-subject SD. Base
model was adjusted for sex, age, obesity, smoking and drinking, history of cardiovascular disease, diabetes mellitus,
hyperlipidemia, and treatment with antihypertensive drugs. The adjusted model was additionally adjusted for systolic
BP and heart rate. The fully adjusted model was additionally adjusted for systolic BP, heart rate, SD of systolic BP,
and SD of heart rate (forced in the same model).
Significance of hazard ratios: †P0.06; ‡P0.05; §P0.01; P0.00143 (0.05/35, Bonferroni correction).
Table 2. Hazard Ratios for Cause-Specific Cardiovascular Mortality According to Blood Pressure and Heart Rate
Parameters at Entry
Mortality Stroke* Cerebral Infarction* Cardiac* Myocardial Infarction*
Deaths, n 83 51 85 33
Base model
Systolic BP, mm Hg 1.43 (1.13 to 1.80)§ 1.55 (1.15 to 2.08)§ 1.24 (0.98 to 1.57) 1.17 (0.80 to 1.72)
Heart rate, bpm 1.27 (1.06 to 1.53)§ 1.14 (0.90 to 1.45) 1.20 (0.99 to 1.46)† 0.98 (0.69 to 1.38)
Adjusted
SD of systolic BP, mm Hg 1.41 (1.15 to 1.73) 1.46 (1.14 to 1.89)§ 1.13 (0.91 to 1.40) 1.01 (0.71 to 1.44)
SD of heart rate, bpm 1.17 (0.96 to 1.43) 1.16 (0.89 to 1.51) 1.30 (1.09 to 1.55)§ 1.43 (1.10 to 1.86)§
Fully adjusted
Systolic BP, mm Hg 1.29 (1.01 to 1.64)‡ 1.38 (1.02 to 1.88)‡ 1.22 (0.96 to 1.56) 1.20 (0.80 to 1.79)
Heart rate, bpm 1.25 (1.02 to 1.52)‡ 1.15 (0.88 to 1.50) 1.09 (0.89 to 1.33) 0.85 (0.60 to 1.21)
SD of systolic BP, mm Hg 1.38 (1.12 to 1.72)§ 1.46 (1.11 to 1.91)§ 1.02 (0.81 to 1.29) 0.87 (0.59 to 1.27)
SD of heart rate, bpm 1.06 (0.84 to 1.33) 1.01 (0.74 to 1.38) 1.30 (1.08 to 1.56)§ 1.47 (1.13 to 1.92)§
*Hazard ratios (95% CIs) reflect risk associated with an increase in parameters of 1 between-subject SD. Base model was adjusted for sex, age,
obesity, smoking and drinking, history of cardiovascular disease, diabetes mellitus, hyperlipidemia, and treatment with antihypertensive drugs. The
adjusted model was additionally adjusted for systolic BP and heart rate. The fully adjusted model was additionally adjusted for systolic BP, heart rate,
SD of systolic BP, and SD of heart rate (forced in the same model).
Significance of hazard ratios: †P0.06; ‡P0.05; §P0.01; P0.00143 (0.05/35, Bonferroni correction).
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ity of measurement might, thus, have been responsible for
higher variability of home blood pressure values and might
account for the relationship between such variability and
prognosis. Variations in patient activities before measurement
may still represent a source of hemodynamic variability.
Increased variability may also reflect underlying disease
states. Arterial stiffness caused by aging and hypertension can
magnify random blood pressure changes and increase vari-
ability. Autonomic dysfunction can also cause swings in
hemodynamic variables. Elevated variability may, thus, only
offer a marker of the above-mentioned conditions rather than
an independent risk factor. Elevated variability of blood
pressure could also be derived from an elevated level of blood
pressure. Level of blood pressure remained a major con-
founder, although we adjusted the level of home blood
pressure in Cox regression analyses.
Poor drug compliance by patients on treatment with antihy-
pertensive therapy might have played a role in increasing blood
pressure variability and could result in poor prognosis via
inadequate blood pressure control in medical practice. Irregular
antihypertensive drug administration may possibly have affected
not only blood pressure variability but also heart rate variability.
The attenuation of antihypertensive therapy could increase
events. However, after excluding patients taking antihyperten-
sive medications, similar results were observed in terms of the
prediction of blood pressure and heart rate variabilities for
cardiovascular mortality (Table S5). Poorer adherence to therapy
alone, therefore, may not explain the relationship between larger
variability and cardiovascular mortality.
We found adverse effects of increased day-by-day variabil-
ity for both blood pressure and heart rate at home. Con-
versely, short-term variability of both blood pressure6,11 and
heart rate6,12–14 reportedly displays an opposite prognostic
significance. This discrepancy between existing evidence and
the present study is probably attributable to the noncontribu-
tion of baroreflex function to day-by-day variability. An
inverse relation between short-term blood pressure and heart
rate variabilities reflects baroreflex function.15 However,
day-by-day variability of blood pressure positively correlates
with that of heart rate (r0.28). Age did not correlate with
day-by-day variability of heart rate (r0.027), although
beat-by-beat heart rate variability is known to be negatively
associated with age.16 The link found in the present study
could possibly depend on other confounding factors, such as
the effects of environmental conditions (eg, mental and
physical stress causing simultaneous elevations in blood
pressure and heart rate in response to activation of the
sympathetic nervous system).
In the present study, both variability and level of home
blood pressure were predictive of stroke but not cardiac
disease (Table 2). For the level of home blood pressure, this
observation is not completely surprising. In Asia, the associ-
ation between blood pressure level and stroke is stronger than
the association between blood pressure level and ischemic
heart disease.17 Moreover, the incidence of and mortality rate
because of stroke are higher than the incidence of and
mortality rate because of myocardial infarction in Japan.10 In
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Figure 2. Absolute 10-year risk of total, noncardio-
vascular, cardiovascular, cardiac, and stroke mor-
tality in relation to SD of systolic blood pressure
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regression, risks were standardized to central ten-
dencies in the other cardiovascular risk factors
used in Table 1. The SD of blood pressure and
heart rate spans the 5th to 95th percentile interval.
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fact, in the present study, the number of deaths from stroke
was more than double that from myocardial infarction. Such
characteristics of the study population may explain why we
observed the predictive power of home blood pressure level
only for stroke and not for cardiac disease. In relation to the
prognostic significance of home blood pressure variability, no
data are available in the literature. Thus, whether these
findings are because of specific characteristics of the Japa-
nese population remains to be determined. The present
findings await testing in different ethnic groups.
Study Limitations
The present study must be interpreted within the context of
the potential limitations. First, the analysis rested exclusively
on Japanese patients and might, therefore, not be representa-
tive of non-Asian or non-Japanese subjects. Second, the study
population predominantly included middle-aged and elderly
individuals. This imbalance in age distribution might, to some
extent, limit the external validity of the findings. Third, the
quality of the measurement procedure could have affected
blood pressure variability, although we asked participants to
measure blood pressure under relatively controlled condi-
tions. Fourth, although information on smoking habits (cur-
rent1) was obtained using a standardized questionnaire, we
did not collect data on the number of cigarettes smoked per
day or smoking years. This is probably why we failed to
identify any significant association between smoking and
cardiovascular mortality (hazard ratio: 1.24; P0.30). Fifth,
the present results could not be confirmed by an analysis of
variability in office blood pressure, as we did not have data on
both daily and monthly measurements of office blood pressure.
Perspectives
To the best of our knowledge, the present study provides the
first prospective evidence that, in Japanese populations,
day-by-day variability might predict cardiovascular mortality.
This index adds to the stratification of risk based on self-
measurements of blood pressure and heart rate at home. Our
observational study was unable to resolve the issue of how to
treat patients with high variability of blood pressure and heart
rate. No detailed information on the factors that affect
day-by-day variability has been published. Urgent clarifica-
tion of modifiable factors that affect blood pressure and heart
rate variability appears warranted to reduce the risk of
cardiovascular death. Until this knowledge becomes avail-
able, our current opinion is that careful management of global
cardiovascular risk is important for high-risk patients with
high day-by-day blood pressure and heart rate variability.
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